unknown
Stage
About
Adaxion Therapeutics develops biologic therapies for immune-mediated and inflammatory diseases by using a proprietary ADAx platform that reduces immunogenicity through targeted elimination of therapeutic-specific B cells.
Explore Adaxion Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.